Formulations driving drug export growth: Pharmexcil chairman Namit Joshi

Indian pharmaceutical exports are set to reach a new high of $32 billion this fiscal year. This growth is driven by formulations, especially in Europe, Africa, and Latin America. Despite challenges in the US market and global quality checks, the industry shows resilience. Steady demand and normalizing supply chains support this positive outlook.